Disseminated Fusarium oxysporum Infection in Hemophagocytic Lymphohistiocytosis by Albisetti, M. et al.
364 Infection 32 · 2004 · No. 6 © URBAN & VOGEL
Disseminated Fusarium oxysporum Infection in 
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Abstract
The portal of entry of disseminated Fusarium spp. infections 
is still not clearly defined. We report on a disseminated 
Fusarium oxysporum infection occurring during a long period 
of severe neutropenia in a child with hemophagocytic 
lymphohistiocytosis. A nasogastric feeding tube was the 
possible source of entry of the fungus.
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Introduction
Fusarium spp. are soilborne fungi, known to be pathogenic 
for plants, animals, and humans [1]. In humans, Fusarium 
spp. can cause localized or invasive disease [2]. Dissemi-
nated infections only occur in immunocompromised pa-
tients, particularly those with severe hematologic dis-
orders, and are usually related to severe and prolonged 
neutropenia [3–7]. 
Potential portals of entry reported include onychomy-
cosis; the respiratory tract, in particular paranasal sinuses, 
the gastrointestinal tract, and a central venous line (CVL). 
However, in many cases the entry sites of disseminated 
Fusarium infections remain unclear. The present case sug-
gests that nasogastric tubes (NGTs) should also be consid-
ered as possible mediators of entry of Fusarium infections 
in immunocompromised patients.
Case Report
A 2-year-old boy with hemophagocytic lymphohistiocytosis 
(HLH) was evaluated in our outpatient clinic because of a spik-
ing fever lasting 2 days. Hemophagocytic lymphohistiocytosis 
was diagnosed 4 months earlier, when the child was evaluated 
for prolonged fever, hepatosplenomegaly, and pancytopenia. 
Upon diagnosis of HLH, the child had an intravascular catheter 
(Port-A-Cath®) inserted. Subsequently, treatment with high-dose 
prednisone and antithymocyte globulin was started, followed by 
continuous immunosuppression therapy with cyclosporin A. 
Physical examination revealed an afebrile child in good gen-
eral condition with hepatomegaly and splenomegaly of 1 cm and 
2 cm below the costal margin, respectively. A complete blood cell 
count showed a white cell count of 2,900/mm3 with 33% neutro-
phils, and 31% lymphocytes, hemoglobin of 96 g/l, and platelet 
count of 196,000/mm3. Biochemistry showed a C-reactive pro-
tein concentration of 29 mg/l (norm: < 4), and a ferritin level of 
4,250 µg/l (norm: 10–180), while fibrinogen and triglycerides were 
normal. Blood drawn from the Port-A-Cath® was cultured for 
bacteria, and the child was discharged home the same day. 
Two days later, he was admitted to the hospital because the 
blood cultures grew Staphylococcus epidermidis. Antibiotic ther-
apy with teicoplanin was started, and the Port-A-Cath® replaced 
with a CVL. Over the next 10 days, HLH relapsed with continu-
ous fever, increasing pancytopenia with marked neutropenia (ab-
solute neutrophil count < 500/mm3), hypofibrinogenemia, hyper-
triglyceridemia, and both ferritin and neopterin levels increasing 
up to 150,000 µg/l  and 38.29 ng/l (norm: < 2.50), respectively. 
Empiric meropenem and liposomal amphotericin B at daily doses 
of 60 mg/kg and 3 mg/kg, respectively, were added to the anti-
microbial regimen. The child’s general conditions deteriorated. 
On day 12, he developed a respiratory distress syndrome requir-
ing mechanical ventilation for 1 week. Immunosuppression with 
dexamethasone, vepeside, and intrathecally administered metho-
trexate was started according to the HLH-94 treatment protocol 
of the First International HLH Study 1994 [8]. The treatment re-
sulted in clinical and biochemical remission within 10 days but se-
vere pancytopenia with marked neutropenia persisted. Liposomal 
amphotericin B, meropenem, and teicoplanin were discontinued 
after 14, 20 and 22 days, respectively. During this time, the feeding 
was supported exclusively through an NGT.
On day 27, the child developed fever, progressive severe my-
algias, vomiting, and diarrhea. Hematologic profile and biochem-
istry showed a persistent pancytopenia with profound neutrope-
nia but no signs suggesting HLH relapse. Repeated microbiologic 
investigations including blood cultures drawn from the CVL, oral 
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swabs, urine, and fecal samples remained negative. Empirical 
treatment with meropenem and teicoplanin was restarted. Ten 
days later, he developed multiple erythematous subcutaneous 
nodules, and painful erythematous macules and papules with 
progressive central infarction on the face, trunk, and extremities 
(Figure 1). A swelling of the right side of the face, eye, and neck, 
ipsilateral to the NGT, also occurred. Conventional radiography 
revealed a diffuse opacification of the maxillary sinuses.
A histology of skin biopsy demonstrated a dermal inflam-
matory lymphocytic cell infiltrate. Both the periodic acid-Schiff 
and the silver stain revealed numerous septate branching hyphae 
around and within dermal blood vessels, many of which contained 
thrombi. Cultures of skin biopsy specimens grew Fusarium oxy-
sporum, which was subsequently isolated also in fecal samples. 
Identification of F. oxysporum was based on the presence of 
sickled-appearing macroconidia, and short monophialides bear-
ing single-celled microconidia in slide cultures [9]. The minimal 
inhibitory concentrations of amphotericin B and itraconazole, as 
determined by the colorimetric microdilution method [9], were 
1 mg/l and 4 mg/l, respectively. Repeated blood cultures remained 
negative. 
On day 46, concomitant intravenous administration of ampho-
tericin B and granulocyte colony-stimulating factor at daily doses 
of 1.2 mg/kg and 5 µg/kg, respectively, was started. On day 49, the 
NGT was removed but neither studies to detect macroscopic or 
microscopic changes suggesting colonization by filamentous fungi, 
nor cultures were performed. After 10 days, progressive increase 
in the white blood cell count with simultaneous resolution of fever 
and cutaneous lesions occurred. After 6 weeks of intravenous an-
tifungal therapy, the child was discharged home with oral itracon-
azole at a dose of 10 mg/kg while continuing immunosuppression 
according to the HLH-94 protocol [8]. Itraconazole was chosen 
for oral prophylaxis, since the compound voriconazole that can be 
also administered orally was then not available to us.
Discussion
Fusarium spp. are soil saprophytes causing diseases in 
plants and animals. While long known to cause localized 
infections also in humans, Fusarium spp. represent an 
increasing cause of disseminated infections among im-
munocompromised patients, especially those with severe 
hematologic disease [1–7]. As in our child, disseminated 
Fusarium infections usually develop during a profound 
and prolonged bone marrow aplasia, and show a typical 
clinical course including persistent fever despite adequate 
antimicrobial therapy, myalgia, and disseminated cutane-
ous lesions (Figure 1) [2]. Cutaneous lesions are present in 
more than 80% of patients with disseminated fusariosis, 
and usually develop at an early stage of the disease as wide-
spread erythematous macules, papules, and nodules with 
progressive central infarction [2]. Occasionally, cellulitis 
of the face, or extremities with or without fasciitis has also 
been reported [10].
Portals of entry of disseminated fusariosis are not 
clearly defined. Most likely reported portals of entry in-
clude disrupted skin and respiratory tract mucosal barriers, 
particularly in patients with onychomycosis and sinusitis, 
respectively. Colonization of the gastrointestinal tract due 
to ingestion of contaminated food has also been reported 
[2, 11–13]. Also, indwelling catheters including CVL, and 
peritoneal dialysis catheters have been identified as poten-
tial entry sites of fusarial infection [1, 11–14]. In several 
of these cases, the role of indwelling catheters as portals 
of entry was supported by both the identification of Fu-
sarium spp. by catheter tip cultures and the demonstration 
of the ability of Fusarium spp. to colonize and invade silas-
tic catheters by electron microscopy, suggesting that other 
foreign-bodies may also represent an important source of 
disseminated fusariosis [1]. The presence of an NGT in our 
patient may have played an important role in promoting 
colonization of both the maxillar sinuses and the gastro-
intestinal tract with F. oxysporum, resulting in localized 
infection and subsequently dissemination during the long 
period of neutropenia. The present case strongly suggests 
that NGTs should be considered potential mediators of 
entry of Fusarium spp. in immunocompromised patients. 
Nasogastric tubes should therefore be used cautiously or 
probably proscribed in patients with severe neutropenia.
Disseminated Fusarium infections are associated with 
a high mortality rate [5]. Rapid diagnosis is an essential 
prerequisite for prompt antifungal therapy and survival of 
patients [3, 5, 13–15]. Although a high rate of isolation of 
Fusarium spp. from the bloodstream is reported, in several 
cases of invasive fusariosis, repeated blood cultures remain 
negative as in our patient [6–7, 12, 15]. The present case 
shows that knowledge of the cutaneous manifestations of 
Fusarium infections along with early histology and culture 
of skin biopsy specimens can accelerate the diagnosis, thus 
allowing prompt optimal treatment, and probably increas-
ing the survival rate.
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